Business
PHBI – Pharmagreen Plans To Transition Cannabis Industry Economics Making Adoption Of Its Proprietary Plant Tissue Technology An Industry Standard
PHBI – Pharmagreen Plans To Transition Cannabis Industry Economics Making Adoption Of Its Proprietary Plant Tissue Technology An Industry Standard.
About this update from Pharmagreen Biotech Inc.
[{"type":"text","content":"\n CARSON CITY, NV, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today released a second management update form CEO Peter Wojcik.  Today’s update provides further information on the company’s strategy to convert the revenue potential of its proprietary intellectual property into realized revenue.  The first update can be reviewed and the following link: Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset   Today’s update is included in its entirety below: CEO Peter Wojcik Strategic Update The transition of Pharmagreen’s revenue potential derived from its proven intellectual property asset will be built on the foundation of executive talent that has converged at Pharmagreen to transform the cannabis industry by making Pharmagreen’s proprietary tissue culture the industry standard for industrial grow operations. Pharmagreen has a proprietary tissue culture process called “Chibafreen” that can be applied to the cannabis industry to increase the scalability of industrial grow operations at the same time preserving genetic purity and enhancing quality production. See my update published last week to learn more about our Chibafreen proprietary process. As the Pharmagreen CEO, I am approaching the cannabis industry with Chibafreen as an economic change agent for the cannabis industry.  Yes, Chibafreen is a differentiator for Pharmagreen as a proprietary technology, but its value will be realized and monetized through its potential to positively impact the economics of the cannabis industry with the improved efficiencies that it can deliver. I bring to Pharmagreen a strong history of economics knowledge and experience that I have leveraged to develop a strong busines strategy for Pharmagreen.  I am a University of Regina alum, and I bring valuable experience with a number of previous high-valued exists built from startups.  My career experience also includes extensive research with cannabis as a therapeutic agent. Pharmagreen has absolutely the best COO in place to manage our Chibafreen proprietary plant tissue culture differentiation.  Dr. Fawzia Afreen’s extraordinary career has spanned almost two decades as an expert in plant horticulture, tissue culture, and production. In additi...